
The biotech industry is poised for substantial expansion due to growing new drug formulations, the rising prevalence of personalized medicine, and several government initiatives and funding in the space. Hence, it seems wise to scoop up shares of robust biotech companies Biogen Inc. (BIIB), Alkermes plc (ALKS), and Theratechnologies Inc. (THTX) this month.
Let’s understand this in detail.